Explore the categories so you can find more about your search.

Categorie > Pharma Industry

European Medicines Agency Recommends Withdrawal Of Marketing Authorisations For Cough Medicines Containing Clobutinol

Categorie : Pharma Industry
Finalising a review of the safety of clobutinol-containing cough medicines in the European Union (EU), the European Medicines Agency (EMEA) concluded that the risks of these medicines are greater than their benefits and recommended that the marketing authorisations for these medicines be ...

read more Finalising a review of the safety of clobutinol-containing cough medicines in the European Union (EU), the European Medicines Agency (EMEA) concluded that the risks of these medicines are greater than their benefits and recommended that the marketing authorisations for these medicines be read more Sun Oct 2007 Sun Oct 2007

APhA, Lexi-Comp Announce Release Of New Drug Information Solution For Community Pharmacists

Categorie : Pharma Industry
The American Pharmacists Association (APhA), the national professional society of pharmacists, and Lexi-Comp, a leading provider of clinical content for the health care industry, have announced the release of Lexi-Comp® ONLINE™ for Community Pharmacy. The online service, created ...

read more The American Pharmacists Association (APhA), the national professional society of pharmacists, and Lexi-Comp, a leading provider of clinical content for the health care industry, have announced the release of Lexi-Comp® ONLINE™ for Community Pharmacy. The online service, created read more Sun Oct 2007 Sun Oct 2007

Hospira's Biosimilar Epoetin Retacrit™ Receives Positive Opinion Recommending EU Approval

Categorie : Pharma Industry
Hospira (NYSE: HSP), a leading global hospital products company, announced that it has received a "positive opinion" recommending European Union (EU) approval for Retacrit (epoetin zeta), a treatment for anemia associated with chronic renal failure and chemotherapy-induced anemia. Retacrit is a ...

read more Hospira (NYSE: HSP), a leading global hospital products company, announced that it has received a read more Sun Oct 2007 Sun Oct 2007

ASHP Educates Pharmacists About Risks To Celiac Patients From Gluten In Medications

Categorie : Pharma Industry
ASHP is alerting pharmacists about the safety risks that unlabeled gluten in medications pose for patients with celiac disease, as part of USA Weekend's Make a Difference Day. USA Weekend is partnering with the National Foundation for Celiac Awareness to raise awareness about celiac disease during ...

read more ASHP is alerting pharmacists about the safety risks that unlabeled gluten in medications pose for patients with celiac disease, as part of USA Weekend's Make a Difference Day. USA Weekend is partnering with the National Foundation for Celiac Awareness to raise awareness about celiac disease during read more Sun Oct 2007 Sun Oct 2007

BIO Statement: Industry Praises California Governor For Supporting Biotechnology

Categorie : Pharma Industry
Biotechnology Industry Organization (BIO) Executive Vice President for Food and Agriculture Sharon Bomer Lauritsen issued the following statement on California Governor Arnold Schwarzenegger's veto of SB 63: California Governor Schwarzenegger vetoed Senate Bill 63, and showed his support for the mo ...

read more Biotechnology Industry Organization (BIO) Executive Vice President for Food and Agriculture Sharon Bomer Lauritsen issued the following statement on California Governor Arnold Schwarzenegger's veto of SB 63: California Governor Schwarzenegger vetoed Senate Bill 63, and showed his support for the mo read more Sun Oct 2007 Sun Oct 2007

Health Advocacy Groups Seek To End Barriers In Accessing Funding For Vital Medical Research

Categorie : Pharma Industry
In a letter to Congressional leaders, 52 patient advocacy and medical specialty groups urged for the restoration of eligibility for small biotechnology companies to compete for Small Business Innovation Research (SBIR) grants, a federal program that provides a vital source of funding for new biomedi ...

read more In a letter to Congressional leaders, 52 patient advocacy and medical specialty groups urged for the restoration of eligibility for small biotechnology companies to compete for Small Business Innovation Research (SBIR) grants, a federal program that provides a vital source of funding for new biomedi read more Sun Oct 2007 Sun Oct 2007

U.S. Lawmakers Should Not Condone Efforts By Thailand To Issue Compulsory Licenses For Antiretrovirals, Opinion Piece Says

Categorie : Pharma Industry
U.S. lawmakers should not praise Thailand and other countries for issuing compulsory licenses to manufacture generic versions of patented antiretroviral drugs, Sally Pipes -- president and CEO of the Pacific Research Institute, which partially is funded by the pharmaceutical industry -&# ...

read more U.S. lawmakers should not praise Thailand and other countries for issuing compulsory licenses to manufacture generic versions of patented antiretroviral drugs, Sally Pipes -- president and CEO of the Pacific Research Institute, which partially is funded by the pharmaceutical industry -&# read more Sun Oct 2007 Sun Oct 2007

Netto Foodstores Will Control Sales Of Analgesics, But Poundland And The 99p Store Continue To Refuse, UK

Categorie : Pharma Industry
The Medicines and Healthcare products Regulatory Agency (MHRA) welcomes recent assurances given by Netto Foodstores Ltd that the food store will restrict sales of analgesics (e.g. paracetamol, aspirin and ibuprofen) to a maximum of two packs of 16. Netto joins a long list of major retailers who have ...

read more The Medicines and Healthcare products Regulatory Agency (MHRA) welcomes recent assurances given by Netto Foodstores Ltd that the food store will restrict sales of analgesics (e.g. paracetamol, aspirin and ibuprofen) to a maximum of two packs of 16. Netto joins a long list of major retailers who have read more Sun Oct 2007 Sun Oct 2007

Medicines For The Few - How Can Society Better Understand The Reality Of Medicines For Rare Diseases?

Categorie : Pharma Industry
One in 33 babies is born with a rare and serious genetic disease - most of which have no treatment(1). Yet the burden of rare diseases is immense and affects millions of individuals across Europe(2). [click link for full article] ...

read more One in 33 babies is born with a rare and serious genetic disease - most of which have no treatment(1). Yet the burden of rare diseases is immense and affects millions of individuals across Europe(2). [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Change Needed In European Drug Regulations, Experts Believe

Categorie : Pharma Industry
To make sure that the needs of doctors and patients are meet European drug regulations should be modified, say experts in an article in the British Medical Journal (BMJ), this week's issue. [click link for full article] ...

read more To make sure that the needs of doctors and patients are meet European drug regulations should be modified, say experts in an article in the British Medical Journal (BMJ), this week's issue. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

American Medical Student Association Announces Enhanced Pharmfree Scorecard 2.0

Categorie : Pharma Industry
The American Medical Student Association (AMSA), the nation's largest, independent medical student organization, announces it will release PharmFree Scorecard 2.0, an updated ranking of all 125 U.S. academic centers according to their pharmaceutical influence policies. The scorecard will include a W ...

read more The American Medical Student Association (AMSA), the nation's largest, independent medical student organization, announces it will release PharmFree Scorecard 2.0, an updated ranking of all 125 U.S. academic centers according to their pharmaceutical influence policies. The scorecard will include a W read more Sun Oct 2007 Sun Oct 2007

Targacept Announces Plans To Develop Enantiomer Of Mecamylamine As Augmentation Therapy For Depression

Categorie : Pharma Industry
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), announced plans to advance TC-5214, one of two enantiomers of mecamylamine hydrochloride, into clinical development as an augmentation therapy for patien ...

read more Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), announced plans to advance TC-5214, one of two enantiomers of mecamylamine hydrochloride, into clinical development as an augmentation therapy for patien read more Sun Oct 2007 Sun Oct 2007

Advance Media Registration For Pacific Rim Summit On Industrial Biotechnology & Bioenergy Now Available Online

Categorie : Pharma Industry
Advance media registration is now available for the Pacific Rim Summit on Industrial Biotechnology & Bioenergy. The Summit will take place Nov. 14-16, 2007 at the Hilton Hawaiian Village Beach Resort in Honolulu and is co-hosted by the Biotechnology Industry Organization (BIO), the Amer ...

read more Advance media registration is now available for the Pacific Rim Summit on Industrial Biotechnology & Bioenergy. The Summit will take place Nov. 14-16, 2007 at the Hilton Hawaiian Village Beach Resort in Honolulu and is co-hosted by the Biotechnology Industry Organization (BIO), the Amer read more Sun Oct 2007 Sun Oct 2007

North American Scientific Receives Notice Of Nasdaq Listing Hearing

Categorie : Pharma Industry
North American Scientific, Inc. (Nasdaq:NASI) announced that it received a letter from The Nasdaq Stock Market ("Nasdaq") dated October 19, 2007 providing formal notice that the Nasdaq Listing Qualifications Panel will consider the Company's appeal of Nasdaq's delisting action announced by the Compa ...

read more North American Scientific, Inc. (Nasdaq:NASI) announced that it received a letter from The Nasdaq Stock Market ( read more Sun Oct 2007 Sun Oct 2007

Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes In Complex Lesions

Categorie : Pharma Industry
Boston Scientific Corporation (NYSE: BSX) announced nine-month data from the pivotal TAXUS ATLAS Small Vessel and Long Lesion studies, which evaluate the TAXUS™ Liberte™ Paclitaxel-Eluting Stent System in complex lesions. The TAXUS Liberté 2. [click link for full ar ...

read more Boston Scientific Corporation (NYSE: BSX) announced nine-month data from the pivotal TAXUS ATLAS Small Vessel and Long Lesion studies, which evaluate the TAXUS™ Liberte™ Paclitaxel-Eluting Stent System in complex lesions. The TAXUS Liberté 2. [click link for full ar read more Sun Oct 2007 Sun Oct 2007

Medical Organizations Pledge Support For Gift Disclosure Bill; Pharmacy Groups Lobby To Prevent Changes To Medicaid Reimbursement Formula

Categorie : Pharma Industry
Summaries of recently published articles tied to the pharmaceutical trade appear below.Gift disclosure: Three medical organizations at a press conference on Monday pledged their support for a bill (S 2029) that would require drug companies to release physician payment and contribution data, [click ...

read more Summaries of recently published articles tied to the pharmaceutical trade appear below.Gift disclosure: Three medical organizations at a press conference on Monday pledged their support for a bill (S 2029) that would require drug companies to release physician payment and contribution data, [click read more Sun Oct 2007 Sun Oct 2007

MHRA invites researchers to access our data, UK

Categorie : Pharma Industry
The Medicines and Healthcare products Regulatory Agency (MHRA) is encouraging those in the research community to apply to use valuable data from the General Practice Research Database (GPRD) and the Yellow Card Scheme to help their studies to protect public health. The call by the MHRA comes on the ...

read more The Medicines and Healthcare products Regulatory Agency (MHRA) is encouraging those in the research community to apply to use valuable data from the General Practice Research Database (GPRD) and the Yellow Card Scheme to help their studies to protect public health. The call by the MHRA comes on the read more Sun Oct 2007 Sun Oct 2007

Markup Date Delayed For Generic Biotechnology Drug Bill

Categorie : Pharma Industry
The June 13 markup date for a Senate bill that would allow FDA to approve generic versions of biotechnology drugs has been pushed back a week, according to a spokesperson for Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.), CongressDaily reports (Edney, Congress ...

read more The June 13 markup date for a Senate bill that would allow FDA to approve generic versions of biotechnology drugs has been pushed back a week, according to a spokesperson for Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.), CongressDaily reports (Edney, Congress read more Sun Jun 2007 Sun Jun 2007

Certified Pharmaceutical Industry Professional - ISPE-PCC Offers New Credential; First Exam Available In July

Categorie : Pharma Industry
Enhanced credibility; peer respect and recognition; greater opportunities for professional advancement; and a competitive edge when job seeking, are some of the benefits that pharmaceutical manufacturing professionals can gain with certification as a Certified Pharmaceutical Industry ProfessionalSM ...

read more Enhanced credibility; peer respect and recognition; greater opportunities for professional advancement; and a competitive edge when job seeking, are some of the benefits that pharmaceutical manufacturing professionals can gain with certification as a Certified Pharmaceutical Industry ProfessionalSM read more Fri Jun 2007 Fri Jun 2007

FDA Lacks Personnel, Funding To Adequately Inspect Prescription Drug Imports, According To CongressDaily

Categorie : Pharma Industry
FDA has insufficient personnel and funding to adequately inspect the safety and effectiveness of prescription drugs manufactured at foreign-owned firms and imported to the U.S., according to a CongressDaily investigation. [click link for full article] ...

read more FDA has insufficient personnel and funding to adequately inspect the safety and effectiveness of prescription drugs manufactured at foreign-owned firms and imported to the U.S., according to a CongressDaily investigation. [click link for full article] read more Thu Jun 2007 Thu Jun 2007

1 | 2 | 3 | 4 next >>>



     


Custom Search